Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tempest Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q2 2021
- Shares held
- 2.20M
- +360.6K (+19.6%) vs. Q2 2021
- Total value
- $31.8M
- +$11.2M (+54.8%) vs. Q2 2021
- New holders
- 3
- 10 more added
- Sold out
- 5
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.58M |
| Q4 2023 | 32 | $9.88M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $8.72M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 647,898 | $9.38M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 359,166 | $5.20M | 0.00% | +298,016+487.4% | Added |
| Rock Springs Capital Management LP | 310,161 | $4.49M | 0.09% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 190,213 | $2.75M | 0.41% | +10.0% | Added |
| FIL Ltd | 129,579 | $1.88M | 0.00% | 00.0% | Unchanged |
| Maven Securities LTD | 126,883 | $1.84M | 0.21% | +20,255+19.0% | Added |
| NEA Management Company, LLC | 117,785 | $1.70M | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 82,698 | $1.20M | 0.00% | +77,779+1,581.2% | Added |
| Monashee Investment Management LLC | 60,000 | $868.0K | 0.16% | −53,644−47.2% | Reduced |
| Ikarian Capital, LLC | 58,803 | $851.0K | 0.19% | −31,062−34.6% | Reduced |
| Renaissance Technologies LLC | 34,104 | $493.0K | 0.00% | +7,237+26.9% | Added |
| Millennium Management LLC | 29,072 | $421.0K | 0.00% | +29,072 | New |
| Geode Capital Management, LLC | 23,301 | $337.0K | 0.00% | +23,301 | New |
| Franklin Resources Inc | 15,240 | $221.0K | 0.00% | +15,240 | New |
| Knott David M | 5,359 | $78.0K | 0.03% | −8,474−61.3% | Reduced |
| Morgan Stanley | 1,989 | $29.0K | 0.00% | +1,263+174.0% | Added |
| Group One Trading, L.P. | 1,502 | $22.0K | 0.00% | +700+87.3% | Added |
| UBS Group AG | 983 | $14.0K | 0.00% | +836+568.7% | Added |
| Bank of America Corp | 912 | $13.0K | 0.00% | +78+9.4% | Added |
| Wells Fargo & Company | 33 | $0 | 0.00% | +25+312.5% | Added |
| Baystate Wealth Management LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Atlas Private Wealth Advisors | 7 | $0 | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −10,477−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −8,643−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −583−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10−100.0% | Sold out |